is compounded tirzepatide being discontinued (GLP-1/GIP) Compound Tirzepatide

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al

Because this large molecule cannot penetrate the inner mitochondrial membrane, an enzyme located on the outer membrane called Carnitine Palmitoyltransferase 1 (CPT1) steps in

It belongs in a class of medication called GLP-1 agonists, which work by stimulating insulin production and slowing the emptying of food out of the stomach, both of which help lower glucose levels

References Villani RG, Gannon J, Self M, Rich PA

10.1016/S2213-8587(13)70218-3 97

Serious Side Effects Pancreatitis : Although rare, there is a risk of pancreatitis, which is inflammation of the pancreas